Analyst Reaffirms Buy Rating on Phathom Pharmaceuticals
On March 8, 2024, analyst Matthew Caufield from HC Wainwright & Co. reiterated a positive outlook on Phathom Pharmaceuticals (NASDAQ: ...
On March 8, 2024, analyst Matthew Caufield from HC Wainwright & Co. reiterated a positive outlook on Phathom Pharmaceuticals (NASDAQ: ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.